Literature DB >> 8880732

Melatonin effects on behavior: possible mediation by the central GABAergic system.

D A Golombek1, P Pévet, D P Cardinali.   

Abstract

The best described function of the pineal hormone melatonin is to regulate seasonal reproduction, with its daily production and secretion varying throughout the seasons or the photoperiod. Additionally, a number of behavioral effects of the hormone have been found. This review describes the effects of melatonin in rodent behavior. We focus on: (a) inhibitory effects (sedation, hypnotic activity, pain perception threshold elevation, anti-convulsive activity, anti-anxiety effects); and (b) direct effects on circadian rhythmicity (entrainment, resynchronization, alleviation of jet-lag symptoms, phase-shifting). Most of these effects are clearly time-dependent, with a peak of melatonin activity during the night. One of the possible mechanisms of action for melatonin in the brain is the interaction with the GABAergic system, as suggested by neurochemical and behavioral data. Finally, some pineal hormone effects might be candidates as putative therapies for several human disorders.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8880732     DOI: 10.1016/0149-7634(95)00052-6

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  36 in total

Review 1.  Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Authors:  Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Gregory M Brown; D Warren Spence; Vijay K Bharti; Charanjit Kaur; Rüdiger Hardeland; Daniel P Cardinali
Journal:  Neurotox Res       Date:  2012-06-28       Impact factor: 3.911

Review 2.  Melatonin, circadian rhythms, and the clock genes in bipolar disorder.

Authors:  Sara Dallaspezia; Francesco Benedetti
Journal:  Curr Psychiatry Rep       Date:  2009-12       Impact factor: 5.285

Review 3.  The rhythmic GABAergic system.

Authors:  D P Cardinali; D A Golombek
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

4.  Exogenous melatonin reproduces the effects of short day lengths on hippocampal function in male white-footed mice, Peromyscus leucopus.

Authors:  J C Walton; Z Chen; J B Travers; R J Nelson
Journal:  Neuroscience       Date:  2013-06-24       Impact factor: 3.590

5.  Magnesium deficiency-dependent audiogenic seizures (MDDASs) in adult mice: a nutritional model for discriminatory screening of anticonvulsant drugs and original assessment of neuroprotection properties.

Authors:  P Bac; P Maurois; C Dupont; N Pages; J P Stables; P Gressens; P Evrard; J Vamecq
Journal:  J Neurosci       Date:  1998-06-01       Impact factor: 6.167

6.  Therapeutic application of melatonin in mild cognitive impairment.

Authors:  Daniel P Cardinali; Daniel E Vigo; Natividad Olivar; María F Vidal; Analía M Furio; Luis I Brusco
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

Review 7.  Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence.

Authors:  Mahshid Yeganeh Salehpour; Adriano Mollica; Saeideh Momtaz; Nima Sanadgol; Mohammad Hosein Farzaei
Journal:  Clin Drug Investig       Date:  2019-07       Impact factor: 2.859

8.  Rapid Communication: Maternal melatonin implants improve fetal oxygen supply and body weight at term in sheep pregnancies.

Authors:  Francisco Sales; Oscar A Peralta; Eileen Narbona; Sue McCoard; Antonio González-Bulnes; Victor H Parraguez
Journal:  J Anim Sci       Date:  2019-02-01       Impact factor: 3.159

Review 9.  Progress in neuroprotective strategies for preventing epilepsy.

Authors:  Munjal M Acharya; Bharathi Hattiangady; Ashok K Shetty
Journal:  Prog Neurobiol       Date:  2007-12-08       Impact factor: 11.685

10.  Melatonin inhibits manganese-induced motor dysfunction and neuronal loss in mice: involvement of oxidative stress and dopaminergic neurodegeneration.

Authors:  Yu Deng; Congcong Jiao; Chao Mi; Bin Xu; Yuehui Li; Fei Wang; Wei Liu; Zhaofa Xu
Journal:  Mol Neurobiol       Date:  2014-06-28       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.